Augmenting autophagy to treat acute kidney injury during endotoxemia in mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23936035.
- Also identified by DOI 10.1371/journal.pone.0069520 and PMC identifier 3728340.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
To determine that 1) an age-dependent loss of inducible autophagy underlies the failure to recover from AKI in older, adult animals during endotoxemia, and 2) pharmacologic induction of autophagy, even after established endotoxemia, is of therapeutic utility in facilitating renal recovery in aged mice. Murine model of endotoxemia and cecal ligation and puncture (CLP) induced acute kidney injury (AKI). Academic research laboratory. C57Bl/6 mice of 8 (young) and 45 (adult) weeks of age. Lipopolysaccharide (1.5 mg/kg), Temsirolimus (5 mg/kg), AICAR (100 mg/kg). Herein we report that diminished autophagy underlies the failure to recover renal function in older adult mice utilizing a murine model of LPS-induced AKI. The administration of the mTOR inhibitor temsirolimus, even after established endotoxemia, induced autophagy and protected against the development of AKI. These novel results demonstrate a role for autophagy in the context of LPS-induced AKI and support further investigation into like interventions that have potential to alter the natural history of disease.
Medical subject headings
- Acute Kidney Injury
- Autophagy
- Endotoxemia
- Protein Kinase Inhibitors